Skip to content

Pulmonx Corporation LUNG Cash Flow Statement

FY'25FY'24FY'23FY'22
-$54M+4.2%-$56.39M+7.3%-$60.84M-3.3%-$58.92M-21.1%
$1.05M-29.4%$1.49M-3.6%$1.55M+2.3%$1.51M+74.5%
$21.23M-7.5%$22.96M+3.9%$22.1M+34.4%$16.45M+56.2%
-$32.38M-2.7%-$31.54M+16.1%-$37.61M+16.6%-$45.08M-8.9%
$452K-68.8%$1.45M+79.3%$807K-38.8%$1.32M-64.1%
$30.5M+74.5%$17.48M+971%-$2.01M
$0$0
$100K
$900K-35.0%$1.39M-93.5%$21.4M+785%$2.42M-45.7%
-$1.15M-$18.18M+61.1%-$46.74M+43.7%
-$32.83M+0.5%-$32.98M+14.1%-$38.42M+17.2%-$46.4M-3.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Pulmonx Corporation generate?
Pulmonx Corporation (LUNG) generated -$29.3M in operating cash flow over the trailing twelve months.
What is Pulmonx Corporation's free cash flow?
After $160.0K of capital expenditures, Pulmonx Corporation's free cash flow was -$29.4M over the trailing twelve months, up 14.2% year over year.
Where does Pulmonx Corporation's cash flow data come from?
Every line is extracted from Pulmonx Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.